A. W. Boersma

发表

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

J. Foekens, M. Riaz, Marijn T. M. van Jaarsveld, 2013, Breast Cancer Research.

The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin.

Marijn T. M. van Jaarsveld, A. W. Boersma, E. Wiemer, 2013, European Journal of Cancer.

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

John W M Martens, Maxime P Look, J. Foekens, 2008, Proceedings of the National Academy of Sciences.

MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation

Manfred Kayser, A. W. Boersma, E. Wiemer, 2010, International Journal of Legal Medicine.

Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin.

A. W. Boersma, G. Stoter, K. Nooter, 1996, Cytometry.

Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer.

A. W. Boersma, M. Flens, F. Bosman, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line.

A. W. Boersma, A. Jochemsen, H. Burger, 1995, British Journal of Cancer.

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.

A. W. Boersma, H. Burger, G. Stoter, 1998, British Journal of Cancer.

Effects of cyclosporin a and verapamil on the intracellular daunorubicin accumulation in chinese hamster ovary cells with increasing levels of drug‐resistance

A. W. Boersma, H. Herweijer, R. Scheper, 1989, International journal of cancer.

Lack of correlation between cisplatin‐induced apoptosis, p53 status and expression of Bcl‐2 family proteins in testicular germ cell tumour cell lines

A. W. Boersma, H. Burger, G. Stoter, 1997, International journal of cancer.

Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitro

A. W. Boersma, J. Verweij, J. Schellens, 1998, Cancer Chemotherapy and Pharmacology.

Distinct p53‐independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines

A. W. Boersma, L. Looijenga, A. Jochemsen, 1999, International journal of cancer.

Impaired cisplatin influx in an A2780 mutant cell line: Evidence for a putative, cis-configuration-specific, platinum influx transporter

A. W. Boersma, I. H. Hamelers, G. Stoter, 2006, Cancer biology & therapy.

Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ-cell tumor cell line NT2, as quantitated by flow cytometry.

A. W. Boersma, H. Burger, G. Stoter, 1997, Cytometry.

Apoptosis of human seminoma cells upon disruption of their microenvironment.

A. W. Boersma, L. Looijenga, J. Oosterhuis, 1996, British Journal of Cancer.

MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines

John W M Martens, Agnes Jager, J. Foekens, 2019, PloS one.

MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR‐145 and miR‐451 as tumor suppressors

Stefan Sleijfer, Cornelis Verhoef, S. Sleijfer, 2014, International journal of cancer.

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

J. Foekens, M. Riaz, Marijn T. M. van Jaarsveld, 2013, Breast Cancer Research.

DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity

Marijn T. M. van Jaarsveld, A. W. Boersma, M. Smid, 2014, Molecular oncology.

miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway

E. Berns, Marijn T. M. van Jaarsveld, A. W. Boersma, 2015, Molecular Cancer.

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells

E. Berns, A. W. Boersma, E. Wiemer, 2013, Oncogene.

Expression of p53, p21/WAF/CIP, Bcl-2, Bax, Bcl-x, and Bak in radiation-induced apoptosis in testicular germ cell tumor lines.

A. W. Boersma, H. Burger, G. Stoter, 1998, International journal of radiation oncology, biology, physics.

MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours

S. Sleijfer, A. W. Boersma, E. Wiemer, 2013, British Journal of Cancer.

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump.

Mariël Brok, A. W. Boersma, E. Wiemer, 2004, Blood.

Imatinib mesylate ( STI 571 ) is a substrate for the breast cancer resistance protein ( BCRP ) / ABCG 2 drug pump

Mariël Brok, A. W. Boersma, E. Wiemer, 2004 .

Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill.

Mariël Brok, A. W. Boersma, H. Burger, 2003, Molecular pharmacology.

SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line.

A. W. Boersma, H. Burger, H. den Dulk, 2001, Cancer research.

MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells

A. W. Boersma, E. Wiemer, S. McKenna, 2016, BMC Cancer.

Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotype.

Mariël Brok, A. W. Boersma, H. Burger, 2002, Molecular pharmacology.

Lysosomal Sequestration Determines Intracellular Imatinib Levels

S. Sleijfer, A. W. Boersma, E. Wiemer, 2015, Molecular Pharmacology.

Lysosomal Sequestration Determines Intracellular Imatinib Levels s

S. Sleijfer, A. W. Boersma, E. Wiemer, 2015 .

Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)

E. Berns, A. W. Boersma, E. Wiemer, 2010, British journal of pharmacology.

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

J. Foekens, J. Klijn, A. Sieuwerts, 2008, Proceedings of the National Academy of Sciences.

The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin.

Marijn T. M. van Jaarsveld, A. W. Boersma, E. Wiemer, 2013, European Journal of Cancer.

Advances in Brief SKY 1 Is Involved in Cisplatin-induced Cell Kill in Saccharomyces cerevisiae , and Inactivation of Its Human Homologue , SRPK 1 , Induces Cisplatin Resistance in a Human Ovarian Carcinoma Cell Line 1

A. W. Boersma, H. Burger, J. Brandsma, 2001 .